Cardinal Health (CAH) Earnings Analysis

Cardinal Health (CAH) next reports earnings on 2026-08-11, consensus EPS 2.42 USD. Last quarter (2026-04-30) it beat with EPS 3.17 USD vs 2.79 USD est (+13.6%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 33.62.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CAH next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate2.42 USD
Revenue estimate65.15B

CAH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-303.17 USD2.79 USD+13.6%Beat
2026-02-052.63 USD2.34 USD+12.4%Beat
2025-10-302.55 USD2.18 USD+17%Beat
2025-05-012.35 USD2.17 USD+8.3%Beat
2025-01-301.93 USD1.74 USD+10.9%Beat
2024-11-011.88 USD1.62 USD+16%Beat
2024-08-141.84 USD1.73 USD+6.4%Beat

Beat rate: 7/7 (100%) over reported quarters with consensus data.

CAH valuation and analyst view

Trailing P/E33.62
Trailing EPS6.634 USD
Price / book-18.30
Dividend yield0.93%
Market cap52.63B
Analyst consensusBuy (18 buy / 15 hold / 0 sell)
Avg price target261 USD

Related research pages

Frequently asked questions

When is Cardinal Health (CAH)'s next earnings date?

Cardinal Health is next scheduled to report on 2026-08-11, with a consensus EPS estimate of 2.42 USD and revenue estimate of 65.15B.

Did CAH beat earnings last quarter?

In its 2026-04-30 report, CAH posted EPS of 3.17 USD versus a 2.79 USD estimate — a beat of 13.6%.

What is CAH's earnings track record?

Over the last 7 reported quarters with consensus data, CAH beat estimates 7 times (100%).

What is CAH's current P/E ratio and EPS?

CAH trades at a trailing P/E of 33.62 on trailing EPS of 6.634042553191489 USD.

What do analysts rate CAH?

Analyst consensus is "Buy" across 33 ratings (0 strong buy, 18 buy, 15 hold, 0 sell, 0 strong sell). Average 12-month price target: 261 USD.